RhumbLine Advisers
HHS icon

RhumbLine Advisers’s Harte-Hanks HHS Stock Holding History

RhumbLine Advisers’s Portfolio HHS Stock Details HHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-1,586
Closed -$26K – 2853
2016
Q3 		$26K Sell
1,586
-470
-23% -$7.74K ﹤0.01% 2859
2016
Q2 		$33K Sell
2,056
-7,166
-78% -$127K ﹤0.01% 2969
2016
Q1 		$233K Buy
9,222
+850
+10% +$26.1K ﹤0.01% 2662
2015
Q4 		$271K Buy
8,372
+276
+3% +$10.3K ﹤0.01% 2634
2015
Q3 		$286K Buy
8,096
+93
+1% +$4.2K ﹤0.01% 2574
2015
Q2 		$477K Sell
8,003
-729
-8% -$49K ﹤0.01% 2367
2015
Q1 		$681K Buy
8,732
+370
+4% +$28.6K ﹤0.01% 2103
2014
Q4 		$647K Buy
8,362
+580
+7% +$37.9K ﹤0.01% 2110
2014
Q3 		$496K Hold
7,782
– – ﹤0.01% 2222
2014
Q2 		$560K Buy
7,782
+298
+4% +$23K ﹤0.01% 2201
2014
Q1 		$662K Sell
7,484
-190
-2% -$14.8K ﹤0.01% 2041
2013
Q4 		$600K Sell
7,674
-400
-5% -$32.6K ﹤0.01% 2144
2013
Q3 		$713K Sell
8,074
-59
-0.7% -$5.4K ﹤0.01% 1990
2013
Q2 		$699K Buy
+8,133
New +$673K ﹤0.01% 2012

Other funds holding HHS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

RhumbLine Advisers's HHS Position: Q4 2016 in Review

RhumbLine Advisers sold out of Harte-Hanks (HHS) in Q4 2016, closing a stake of 1,586 shares — an estimated $26K sold.

RhumbLine Advisers first reported a position in HHS in Q2 2013 and held it in 14 quarters. The position peaked at $713K in Q3 2013. 86 funds tracked by Wall St. Rank hold HHS as of Q4 2016.

  • RhumbLine Advisers reported no remaining Harte-Hanks position as of Q4 2016 after selling out during the quarter.
  • RhumbLine Advisers sold 1,586 Harte-Hanks shares in Q4 2016, an estimated $26K.
  • RhumbLine Advisers first reported a position in Harte-Hanks in Q2 2013 and held it in 14 quarters.
  • RhumbLine Advisers's Harte-Hanks position peaked at $713K in Q3 2013.
  • 86 funds tracked by Wall St. Rank held Harte-Hanks as of Q4 2016.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.